Peter Lynch · Growth at a reasonable price (GARP)
Is Halozyme Therapeutics, Inc. (HALO) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
62/100
Ne correspond pas
3/6 critères validés
Les critères de Peter Lynch, appliqués à HALO
PEG ≤ 1.0
clé-
EPS CAGR ≥ 15%
clé-2.0%
Revenue CAGR ≥ 10%
33.2%
Net margin > 0
23.1%
Comment HALO se classe selon d'autres stratégies
Données financières en direct
Cap. boursière
$12.29B
PER (TTM)
23.3x
ROIC (TTM)
23.65%
Marge brute
76.93%
Autres analyses Peter Lynch
Questions fréquentes
What is HALO's Peter Lynch fit score?
HALO scores 62/100 on our Peter Lynch fit engine. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own HALO?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends HALO.
How often is this score updated?
HALO's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Outil éducatif, pas un conseil en investissement. Les scores sont calculés à partir de données financières publiques selon les critères publiés de chaque stratégie d'investissement. Nous ne prétendons pas que Peter Lynch possède ou recommande HALO personnellement.
